IR Beam Used Before Peripheral Intravenous Catheter Application on Vein Visibility

NCT ID: NCT06569004

Last Updated: 2024-08-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-01

Study Completion Date

2024-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will be conducted in the Oncology and Cardiovascular Surgery (CVS) services of a university hospital. In the research, 30 patients will constitute the control group and 30 patients will constitute the experimental group. A nurse working in the clinics where the study will be conducted will perform the PIVK procedure, and we will randomly select the control and experimental groups and apply light to the area where the PIVK will be applied to the patients in the experimental groups with a flashlight that emits infrared rays for 10 minutes. The nurse will not be aware of whether the radiation application was made to the patient or not. The veins will be evaluated by the nurse performing PIVK. We will fill out the necessary forms in ANNEX 1 (control group) and APPENDIX 2 (experimental group) while the PIVK procedure is applied. After the procedure is completed, the patient's pain, anxiety and satisfaction level during the procedure will be marked. The data will be entered into the SPSS program and evaluated with statistical tests. According to the results, the effect of IR rays used before PIVK application on the patient's pain, anxiety and satisfaction and on the procedure time spent by the nurse for the application will be determined.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A nurse from the ward where the study will be conducted will be contacted and a meeting of approximately 20 minutes will be held about the study. The nurse will fill out the forms before and after inserting the catheter into the patient. Routine procedures such as tourniquet, hand opening and closing will be applied to the control group before catheter application. In the experimental group, catheter application will be made after the IR beam is applied.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Questionnaire

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IR beam used before peripheral intravenous catheter application on vein visibility

IR beam application

Group Type EXPERIMENTAL

randomised study, two group (experimental and control)

Intervention Type DEVICE

Use of IR beam before peripheral intravenous catheter application

control

Only parenteral catheter application

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

randomised study, two group (experimental and control)

Use of IR beam before peripheral intravenous catheter application

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

IR beam

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Are between the ages of 18-70,

* PIVK will be inserted,
* Not receiving anticoagulant treatment,
* Does not have diabetes or peripheral neuropathy,
* No signs of infiltration or thrombophlebitis in the extremity where IR beam will be used,
* Dialysis patients without arteriovenous fistula,
* Does not have any communication problems and whose mental level does not cause any problems in participating in the research,
* Patients who volunteer to participate in the research will be recruited.

Exclusion Criteria

* Sudden movements during PICK insertion,
* Missing patient data
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Karadeniz Technical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sule BIYIK BAYRAM

Associate professor Karadeniz Technical University

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sule BIYIK BAYRAM

Role: STUDY_DIRECTOR

Karadeniz Technical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Şule BIYIK BAYRAM

Trabzon, Ortahisar, Turkey (Türkiye)

Site Status

Şule

Trabzon, , Turkey (Türkiye)

Site Status

Karadeniz Technical University Faculty of Health Sciences

Trabzon, Üniversite, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Şule Bıyık Bayram, phD

Role: CONTACT

4623778866

Merve ÇİÇEK

Role: CONTACT

4633778866

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Merve Çiçek

Role: primary

4623778866

Merve Çiçek

Role: primary

4623778866

Hüdanur Tosun

Role: primary

4623778866

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Karadeniz Tek. Univ. 3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.